poisar

Stock

Sotera Health Company SHC

$19.47-0.38%

Overview

SHC market data

Price History

SHC price chart · 1M
O
19.64
H
19.71
L
19.46
C
19.47
Vol
120,684.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$19.64
Previous Close
$19.54
Day High
$19.71
Day Low
$19.46
52 Week High
$19.72
52 Week Low
$14.27
7 Day Return
+1.38%
30 Day Return
+9.60%
90 Day Return
+24.46%
1 Year Return
+25.99%
Daily Notional Volume
$2.3M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
46.08
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$0.27
Diluted earnings per share over the trailing twelve months.
Beta
1.86
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
9.9%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$13.09 – $19.85
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $5.4B · P/B 8.27 · P/S 4.56.

Company News

10 captured
8-K filing — Sotera Health Co (SHC)SEC EDGAR · Aug 14, 2026, 11:17 AM
Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25Benzinga · Aug 7, 2026, 8:24 PM
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $22Benzinga · Aug 7, 2026, 7:05 PM
Piper Sandler Reiterates Overweight on Sotera Health, Raises Price Target to $25Benzinga · Aug 7, 2026, 5:10 PM
JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18Benzinga · Aug 7, 2026, 4:48 PM
Sotera Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.Benzinga · Aug 6, 2026, 5:39 PM
Sotera Health Q2 Adj. EPS $0.26 Beats $0.24 Estimate, Sales $321.375M Beat $309.391M EstimateBenzinga · Aug 6, 2026, 11:07 AM
Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B to $1.236B-$1.254B vs $1.241B EstBenzinga · Aug 6, 2026, 11:03 AM
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19Benzinga · Jun 24, 2026, 2:50 PM
This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For FridayBenzinga · Jun 5, 2026, 12:55 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock